These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC program report from the United States component (2005). Rhomberg PR, Jones RN. Diagn Microbiol Infect Dis; 2007 Feb; 57(2):207-15. PubMed ID: 16949243 [Abstract] [Full Text] [Related]
5. Meropenem activity against European isolates: report on the MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) 2006 results. Turner PJ. Diagn Microbiol Infect Dis; 2008 Feb; 60(2):185-92. PubMed ID: 17945455 [Abstract] [Full Text] [Related]
7. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007). Nørskov-Lauritsen N, Marchandin H, Dowzicky MJ. Int J Antimicrob Agents; 2009 Aug; 34(2):121-30. PubMed ID: 19342205 [Abstract] [Full Text] [Related]
13. Antimicrobial resistance rates and clonality results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) programme: report of year five (2003). Rhomberg PR, Jones RN, Sader HS, Fritsche TR, MYSTIC Programme Study Group. Diagn Microbiol Infect Dis; 2004 Aug; 49(4):273-81. PubMed ID: 15313533 [Abstract] [Full Text] [Related]
14. Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006. Zhanel GG, DeCorby M, Nichol KA, Wierzbowski A, Baudry PJ, Karlowsky JA, Lagacé-Wiens P, Walkty A, Mulvey MR, Hoban DJ, Canadian Antimicrobial Resistance Alliance. Diagn Microbiol Infect Dis; 2008 Sep; 62(1):67-80. PubMed ID: 18513913 [Abstract] [Full Text] [Related]
19. Detection of emerging resistance patterns within longitudinal surveillance systems: data sensitivity and microbial susceptibility. MYSTIC Advisory Board. Meropenem Yearly Susceptibility Test Information Collection. Jones RN. J Antimicrob Chemother; 2000 Sep; 46 Suppl T2():1-8. PubMed ID: 11065144 [Abstract] [Full Text] [Related]
20. Activity of meropenem as serine carbapenemases evolve in US Medical Centers: monitoring report from the MYSTIC Program (2006). Rhomberg PR, Deshpande LM, Kirby JT, Jones RN. Diagn Microbiol Infect Dis; 2007 Dec; 59(4):425-32. PubMed ID: 17662557 [Abstract] [Full Text] [Related] Page: [Next] [New Search]